SJS Fact Sheet
This SJS Fact Sheet can be viewed with Adobe Acrobat Reader

• SJS Fact Sheet: This SJS Fact Sheet is in Word Document format.
• Spanish SJS Fact Brochure: This brochure can be viewed with Adobe Acrobat Reader
• Click here to read SJS article in Spanish. It can be viewed with Adobe Acrobat Reader

IVIG Treatment
If started during the beginning stage of SJS IVIG (immunoglobulin treatment) has been successful in treating some SJS patients. It has shortened the course and limited sideeffects. Read about IVIG Treatment

Stevens Johnson Syndrome & Toxic Epidermal Necrolysis
Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are now believed to be variants of the same condition, distinct from erythema multiforme. SJS/TEN is a very rare, acute, serious, and potentially fatal skin reaction in which there is sheet-like skin and mucosal loss. Using current definitions, it is usually, possibly always, caused by medications.
Full article on Stevens Johnson Syndrome, Toxic Epidermal Necrolysis. SJS/TEN. DermNet NZ

Ophthalmologic Management
Very important vision saving treatment: The Ophthalmologic Management of Acute Stevens-Johnson Syndrome, By Darren G. Gregory, MD. To view full article, please [click here]

Products designed by healthcare professionals
Solace Nutrition is a medical nutrition company founded with the intent to develop clinical nutrition products designed for individuals living with chronic disease. Solace Nutrition is dedicated to provide products that meet the nutritional needs that change throughout the lifecycle of individuals living with a chronic disease.

Brandeis studies evaluate visionary approach to improving eyesight
A novel scleral lens developed in Boston proves clinically beneficial in patients who have failed conventional therapies. To view full article please: [click here].

Burn unit treatment of three Stevens Johnson Syndrome cases with Cryopreserved Allograft
Three cases of Stevens-Johnson syndrome are described. This syndrome is characterized by extensive loss of tffe epidermis and other complications. The cutaneous lesions are similar to second-degree burns in their development, and they benefit from temporary coverage with cryopreserved allografts, as may be performed in a Burns Centre.